Impact of seven rounds of mass administration of diethylcarbamazine and ivermectin on prevalence of chronic lymphatic filariasis in south India
Identifieur interne : 006F94 ( Main/Exploration ); précédent : 006F93; suivant : 006F95Impact of seven rounds of mass administration of diethylcarbamazine and ivermectin on prevalence of chronic lymphatic filariasis in south India
Auteurs : J. Yuvaraj [Inde] ; S. P. Pani [Inde] ; P. Vanamail [Inde] ; K. D. Ramaiah [Inde] ; P. K. Das [Inde]Source :
- TM & IH. Tropical medicine & international health [ 1360-2276 ] ; 2008.
Descripteurs français
- Pascal (Inist)
- Wicri :
- geographic : Inde.
- topic : Maladie chronique, Médicament.
English descriptors
- KwdEn :
Abstract
OBJECTIVE To evaluate the impact of seven rounds of mass administration of diethylcarbamazine (DEC) and ivermectin on the prevalence of chronic lymphatic filariasis and to compare it with that observed in a placebo arm in a community-level trial. METHODS Cross-sectional clinical surveys were carried out before and after seven rounds of mass drug administration (MDA). About 54-75% of the target population were treated at each round of MDA. RESULTS After seven rounds, the hydrocele prevalence had declined from the pre-intervention level of 20.5-5.1% (P < 0.05) in the DEC arm, from 23.9% to 10.4% (P < 0.05) in the ivermectin arm and from 20.4% to 10.9% (P < 0.05) in the placebo arm, equivalent to reductions of 75.3%, 56.6% and 46.6%, respectively. The lymphoedema/elephantiasis prevalence declined only marginally and without statistical significance from 3.7% to 3.2%, 4.6% to 3.9% and 2.9% to 2.3% in the DEC, ivermectin and placebo arm. After the seventh MDA, none of the sampled people in the 0-20 age group was found with hydrocele and there was a statistically significant decline in hydrocele prevalence in all other age groups in the communities treated with DEC, the drug known to have macrofilaricidal effect. The impact was relatively less in ivermectin arm. CONCLUSION Repeated DEC administration has the potential to prevent incidence of new hydrocele cases and may resolve the manifestation at least in a proportion of affected people. Apart from reducing the microfilaraemia prevalence and transmission of infection, MDA also results in significant public health benefits by reducing the burden of hydrocele in treated communities.
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000401
- to stream PascalFrancis, to step Curation: 000559
- to stream PascalFrancis, to step Checkpoint: 000395
- to stream Main, to step Merge: 007111
- to stream Main, to step Curation: 006F94
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Impact of seven rounds of mass administration of diethylcarbamazine and ivermectin on prevalence of chronic lymphatic filariasis in south India</title>
<author><name sortKey="Yuvaraj, J" sort="Yuvaraj, J" uniqKey="Yuvaraj J" first="J." last="Yuvaraj">J. Yuvaraj</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Vector Control Research Centre</s1>
<s2>Pondicherry</s2>
<s3>IND</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Inde</country>
<wicri:noRegion>Vector Control Research Centre</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pani, S P" sort="Pani, S P" uniqKey="Pani S" first="S. P." last="Pani">S. P. Pani</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Vector Control Research Centre</s1>
<s2>Pondicherry</s2>
<s3>IND</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Inde</country>
<wicri:noRegion>Vector Control Research Centre</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Vanamail, P" sort="Vanamail, P" uniqKey="Vanamail P" first="P." last="Vanamail">P. Vanamail</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Vector Control Research Centre</s1>
<s2>Pondicherry</s2>
<s3>IND</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Inde</country>
<wicri:noRegion>Vector Control Research Centre</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ramaiah, K D" sort="Ramaiah, K D" uniqKey="Ramaiah K" first="K. D." last="Ramaiah">K. D. Ramaiah</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Vector Control Research Centre</s1>
<s2>Pondicherry</s2>
<s3>IND</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Inde</country>
<wicri:noRegion>Vector Control Research Centre</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Das, P K" sort="Das, P K" uniqKey="Das P" first="P. K." last="Das">P. K. Das</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Vector Control Research Centre</s1>
<s2>Pondicherry</s2>
<s3>IND</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Inde</country>
<wicri:noRegion>Vector Control Research Centre</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">08-0227645</idno>
<date when="2008">2008</date>
<idno type="stanalyst">PASCAL 08-0227645 INIST</idno>
<idno type="RBID">Pascal:08-0227645</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000401</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000559</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000395</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000395</idno>
<idno type="wicri:doubleKey">1360-2276:2008:Yuvaraj J:impact:of:seven</idno>
<idno type="wicri:Area/Main/Merge">007111</idno>
<idno type="wicri:Area/Main/Curation">006F94</idno>
<idno type="wicri:Area/Main/Exploration">006F94</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Impact of seven rounds of mass administration of diethylcarbamazine and ivermectin on prevalence of chronic lymphatic filariasis in south India</title>
<author><name sortKey="Yuvaraj, J" sort="Yuvaraj, J" uniqKey="Yuvaraj J" first="J." last="Yuvaraj">J. Yuvaraj</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Vector Control Research Centre</s1>
<s2>Pondicherry</s2>
<s3>IND</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Inde</country>
<wicri:noRegion>Vector Control Research Centre</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pani, S P" sort="Pani, S P" uniqKey="Pani S" first="S. P." last="Pani">S. P. Pani</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Vector Control Research Centre</s1>
<s2>Pondicherry</s2>
<s3>IND</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Inde</country>
<wicri:noRegion>Vector Control Research Centre</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Vanamail, P" sort="Vanamail, P" uniqKey="Vanamail P" first="P." last="Vanamail">P. Vanamail</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Vector Control Research Centre</s1>
<s2>Pondicherry</s2>
<s3>IND</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Inde</country>
<wicri:noRegion>Vector Control Research Centre</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ramaiah, K D" sort="Ramaiah, K D" uniqKey="Ramaiah K" first="K. D." last="Ramaiah">K. D. Ramaiah</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Vector Control Research Centre</s1>
<s2>Pondicherry</s2>
<s3>IND</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Inde</country>
<wicri:noRegion>Vector Control Research Centre</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Das, P K" sort="Das, P K" uniqKey="Das P" first="P. K." last="Das">P. K. Das</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Vector Control Research Centre</s1>
<s2>Pondicherry</s2>
<s3>IND</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Inde</country>
<wicri:noRegion>Vector Control Research Centre</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">TM & IH. Tropical medicine & international health</title>
<title level="j" type="abbreviated">TM IH, Trop. med. int. health</title>
<idno type="ISSN">1360-2276</idno>
<imprint><date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">TM & IH. Tropical medicine & international health</title>
<title level="j" type="abbreviated">TM IH, Trop. med. int. health</title>
<idno type="ISSN">1360-2276</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anthelmintic</term>
<term>Chronic</term>
<term>Chronic disease</term>
<term>Diethylcarbamazine</term>
<term>Drug</term>
<term>Effusion</term>
<term>Hydrocele</term>
<term>India</term>
<term>Ivermectin</term>
<term>Lymphatic filariasis</term>
<term>Lymphedema</term>
<term>Mass campaign</term>
<term>Parasiticide</term>
<term>Prevalence</term>
<term>South</term>
<term>Tropical medicine</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Diéthylcarbamazine</term>
<term>Ivermectine</term>
<term>Filariose lymphatique</term>
<term>Maladie chronique</term>
<term>Lymphoedème</term>
<term>Hydrocèle</term>
<term>Campagne de masse</term>
<term>Prévalence</term>
<term>Chronique</term>
<term>Sud</term>
<term>Inde</term>
<term>Médicament</term>
<term>Médecine tropicale</term>
<term>Antiparasitaire</term>
<term>Anthelminthique</term>
<term>Epanchement</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Inde</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Maladie chronique</term>
<term>Médicament</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">OBJECTIVE To evaluate the impact of seven rounds of mass administration of diethylcarbamazine (DEC) and ivermectin on the prevalence of chronic lymphatic filariasis and to compare it with that observed in a placebo arm in a community-level trial. METHODS Cross-sectional clinical surveys were carried out before and after seven rounds of mass drug administration (MDA). About 54-75% of the target population were treated at each round of MDA. RESULTS After seven rounds, the hydrocele prevalence had declined from the pre-intervention level of 20.5-5.1% (P < 0.05) in the DEC arm, from 23.9% to 10.4% (P < 0.05) in the ivermectin arm and from 20.4% to 10.9% (P < 0.05) in the placebo arm, equivalent to reductions of 75.3%, 56.6% and 46.6%, respectively. The lymphoedema/elephantiasis prevalence declined only marginally and without statistical significance from 3.7% to 3.2%, 4.6% to 3.9% and 2.9% to 2.3% in the DEC, ivermectin and placebo arm. After the seventh MDA, none of the sampled people in the 0-20 age group was found with hydrocele and there was a statistically significant decline in hydrocele prevalence in all other age groups in the communities treated with DEC, the drug known to have macrofilaricidal effect. The impact was relatively less in ivermectin arm. CONCLUSION Repeated DEC administration has the potential to prevent incidence of new hydrocele cases and may resolve the manifestation at least in a proportion of affected people. Apart from reducing the microfilaraemia prevalence and transmission of infection, MDA also results in significant public health benefits by reducing the burden of hydrocele in treated communities.</div>
</front>
</TEI>
<affiliations><list><country><li>Inde</li>
</country>
</list>
<tree><country name="Inde"><noRegion><name sortKey="Yuvaraj, J" sort="Yuvaraj, J" uniqKey="Yuvaraj J" first="J." last="Yuvaraj">J. Yuvaraj</name>
</noRegion>
<name sortKey="Das, P K" sort="Das, P K" uniqKey="Das P" first="P. K." last="Das">P. K. Das</name>
<name sortKey="Pani, S P" sort="Pani, S P" uniqKey="Pani S" first="S. P." last="Pani">S. P. Pani</name>
<name sortKey="Ramaiah, K D" sort="Ramaiah, K D" uniqKey="Ramaiah K" first="K. D." last="Ramaiah">K. D. Ramaiah</name>
<name sortKey="Vanamail, P" sort="Vanamail, P" uniqKey="Vanamail P" first="P." last="Vanamail">P. Vanamail</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006F94 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 006F94 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Exploration |type= RBID |clé= Pascal:08-0227645 |texte= Impact of seven rounds of mass administration of diethylcarbamazine and ivermectin on prevalence of chronic lymphatic filariasis in south India }}
This area was generated with Dilib version V0.6.31. |